Alnylam Pharmaceuticals, Inc. News - ALNY

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Alnylam Pharmaceuticals, Inc. ALNY NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -1.56 -2.10% 72.68 74.95 72.02 74.24 74.24 18:00:10
more quote information »

Recent News

Date Time Source Heading
7/16/201907:00BWAlnylam and 23andMe Collaborate on +MyFamily Program to..
7/11/201916:16EDGARCurrent Report Filing (8-k)
7/11/201908:30BWAlnylam Pharmaceuticals Announces Transition of Chief..
7/05/201910:10EDGARConfidential Treatment Order (ct Order)
7/02/201916:11EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:10EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:10EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:08EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:08EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:04EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201916:01GLOBEArbutus Sells Part of its ONPATTRO™ (patisiran) Royalty..
7/01/201907:00BWAlnylam Submits Marketing Authorization Application to the..
6/24/201907:00BWAlnylam Presents New ONPATTRO® (patisiran) Results at the..
6/21/201907:00BWAlnylam Announces Progress with RNAi Therapeutics Platform,..
6/18/201908:00BWAlnylam Announces Approval in Japan of ONPATTRO® for the..
6/17/201907:00BWAlnylam Completes Enrollment for ILLUMINATE-A Phase 3 Study..
6/13/201908:00BWAlnylam to Report New Clinical Results for ONPATTRO®..
6/07/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201916:04EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201907:00BWAlnylam Completes Rolling Submission of New Drug Application..
5/31/201907:00BWAlnylam Doses First Patient in Phase 1 Study of ALN-AGT, an..
5/30/201916:00BWAlnylam to Webcast Presentations at Upcoming June Investor..
5/29/201908:00BWAlnylam Announces New Leadership Appointments
5/21/201916:33EDGARCurrent Report Filing (8-k)
5/17/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201907:00BWAlnylam to Webcast Presentation at Bank of America Merrill..
5/03/201916:04EDGARAmended Statement of Ownership (sc 13g/a)
5/02/201917:09EDGARConfidential Treatment Order (ct Order)
5/02/201916:36EDGARQuarterly Report (10-q)
5/02/201910:14EDGARConfidential Treatment Order (ct Order)
5/02/201910:13EDGARConfidential Treatment Order (ct Order)
5/01/201908:46EDGARCurrent Report Filing (8-k)
5/01/201908:00BWAlnylam Pharmaceuticals Reports First Quarter 2019 Financial..
4/30/201916:00BWAlnylam Highlights Progress on Global Market Access for..
4/26/201916:41EDGARCurrent Report Filing (8-k)
4/23/201916:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
4/17/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
4/15/201907:00BWAlnylam Initiates ILLUMINATE-B Phase 3 Pediatric Study of..
4/12/201918:01BWAlnylam Presents Positive Complete Results from ENVISION..
4/10/201909:20EDGARConfidential Treatment Order (ct Order)
4/10/201906:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/09/201916:44EDGARCurrent Report Filing (8-k)
4/08/201916:25EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
See more news about this stock »
Your Recent History
NASDAQ
ALNY
Alnylam Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190717 23:21:20